CanRIO is a network of Canadian rheumatologists and researchers with expertise in the management of the rheumatic complications of cancer immunotherapy. These include the development of new rheumatic conditions which develop during or after treatment with immunotherapy, termed rheumatic immune related adverse events (Rh ir-AE) and on the management of patients with rheumatic disease who are being treated or being considered for treatment with immunotherapy.
Site content continues to be developed and will be updated on a continuous basis as emerging evidence becomes available. Please check back frequently!
To improve the care of cancer patients across Canada receiving immunotherapy, who develop rheumatic complications or have pre-existing autoimmune conditions, through collaboration, education and research.
Would you like to support CanRIO? Your donation will help fund critical research to help us understand how best to diagnose and treat side effects of immunotherapy in cancer patients. Click on the link below to make a donation through Arthritis Research Canada and enter “CanRIO” in the message area to ensure your support is dedicated to CanRIO research projects. https://www.arthritisresearch.ca/donate/
